Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8061642rdf:typepubmed:Citationlld:pubmed
pubmed-article:8061642lifeskim:mentionsumls-concept:C0031046lld:lifeskim
pubmed-article:8061642lifeskim:mentionsumls-concept:C0034065lld:lifeskim
pubmed-article:8061642lifeskim:mentionsumls-concept:C0750729lld:lifeskim
pubmed-article:8061642pubmed:issue3-4lld:pubmed
pubmed-article:8061642pubmed:dateCreated1994-9-16lld:pubmed
pubmed-article:8061642pubmed:abstractTextAmong 121 patients with pulmonary embolism (PE) five (4%) developed pericardial syndrome, connected with PE. Other known causes of pericarditis were ruled out. In 3 cases corticosteroids were administered with anticoagulants and/or fibrinolytic agents without complications. We believe that the clinician considering in similar situations the risk-benefit ratio of anticoagulant or/and fibrinolytic therapy should certainly use corticosteroids and not abstain from the use of anticoagulants and/or fibrinolytic agents in presence of pericardial syndrome after PE. In cases with huge pericardial effusion catheter should be inserted into pericardial space, because of high probability of cardiac tamponade.lld:pubmed
pubmed-article:8061642pubmed:languagepollld:pubmed
pubmed-article:8061642pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8061642pubmed:citationSubsetIMlld:pubmed
pubmed-article:8061642pubmed:statusMEDLINElld:pubmed
pubmed-article:8061642pubmed:issn0867-7077lld:pubmed
pubmed-article:8061642pubmed:authorpubmed-author:PolowiecZZlld:pubmed
pubmed-article:8061642pubmed:authorpubmed-author:FilipeckiSSlld:pubmed
pubmed-article:8061642pubmed:authorpubmed-author:TomkowskiWWlld:pubmed
pubmed-article:8061642pubmed:issnTypePrintlld:pubmed
pubmed-article:8061642pubmed:volume62lld:pubmed
pubmed-article:8061642pubmed:ownerNLMlld:pubmed
pubmed-article:8061642pubmed:authorsCompleteYlld:pubmed
pubmed-article:8061642pubmed:pagination163-5lld:pubmed
pubmed-article:8061642pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:meshHeadingpubmed-meshheading:8061642-...lld:pubmed
pubmed-article:8061642pubmed:year1994lld:pubmed
pubmed-article:8061642pubmed:articleTitle[Pericarditis during the course of pulmonary embolism].lld:pubmed
pubmed-article:8061642pubmed:affiliationKliniki Chorób Wewnetrznych, Instytutu Gru?licy i Chorób P?uc w Warszawie.lld:pubmed
pubmed-article:8061642pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8061642pubmed:publicationTypeEnglish Abstractlld:pubmed